VRTX
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is a Healthcare company (Biotechnology) with a market capitalization of $132.9B. Its Maz Rating is 4.71 out of 5 (A, Strong Buy), ranked against the other companies in its sector.
Factor scores: Valuation 1.47, Growth 4.01, Profitability 4.94, Financial Health 4.73, Momentum 3.96 (as of 2026-10-16).